Diabetes, metabolic syndrome and obesity: targets and therapy 11726 Anson M, Zhao SS, Austin P, Ibarburu GH, Malik RA, Alam U (2023) SGLT2i and GLP-1 RA therapy in type 1 diabetes and reno-vascular outcomes: a real-world study
For those new to self-injection, resources on how to inject semaglutide properly and choosing the best injection sites are essential reading
It may be the preferred choice for patients with established CV disease
Reframing Menopause for Long-Term Health Each year, millions of women pass through one of the most consequential biological transitions of their lives, yet it remains one of the least studied and most poorly understood in mainstream medicine
For patients who have struggled with weight loss (which includes over half of U.S
, The association between GLP-1 receptor agonist and diabetic ketoacidosis in the FDA adverse event reporting system, Nutr